Diabetic neuropathy;Neuropatia cukrzycowa

Polski Merkuriusz Lekarski

Volumn 22, Issue 127, 2007, Pages 66-69

  Chudzik, W ^a,b,c   Kaczorowska, B ^b   Przybyla M ^b   Chudzik, B ^b   Galka M ^b  

^a Clinical Hospital in ód   (Poland)

^b Uniwersytecki Szpital Kliniczny Im WAM   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Diabetic neuropathy; Pathogenesis; Treatment

Indexed keywords

INSULIN;

ANIMAL; ARTICLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; VASCULARIZATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INSULIN; PERIPHERAL NERVES;

EID: 33847059537     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ametov A.S., Barinov A., Dyck P.J. i wsp.: The sensory symptom of diabetic polyneuropathy are improved with Ralpha-lipoic acid: the SYDNEY trial. Diabetes Care, 2003, 26, 770-776.
2. Backonja M., Beydoun A., Edwards K.R., i wsp.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA, 1998, 280, 1831-1836.
3. Czech A., Głowania A.: Neuropatia cukrzycowa autonomiczna: diagnostyka, główne zespoły kliniczne, leczenie. Medycyna Metaboliczna, 2004, 4, 15-32.
4. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 977-986.
5. Drac H., Jȩdrzejowska H.: Neuropatie w cukrzycy. W: Choroby układu nerwowego. Kozubski W. (red.), Liberski P.P. Wydawnictwo Lekarskie PZWL, Warszawa 2004, 313-316.
6. Gaede P., Vedel P., Parving H.H., Pedersen O.: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet, 1999, 353, 617-622.
7. Jackson G.: Sexual dysfunction and diabetes. Int. J. Clin. Pract., 2004, 58 (4), 358-362.
8. Jasik M.: Rozpoznawanie, zapobieganie i leczenie późnych powikłań cukrzycy. Farmacja Polska, 2003, 59 (23), 1060-1073.
9. Jasik M.: Terapia neuropatii cukrzycowej. Przegla̧d Lekarski, 2003, 60, 167-169.
10. Maser R.E., Lenhard M.J.: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J. Clin. Endocrinol. Metab., 2005, 90 (10), 5896-5903.
11. Stassen M.P.: Diabetic gastroparesis. Rev. Med. Liege., 2005, 60 (5-6), 509-515.
12. Sullivan KA.., Feldman E.L.: New developments in diabetic neuropathy. Curr. Opin. Neurol., 2005, 18 (5), 586-590.
13. Tatoń J.: Neuropatia cukrzycowa somatyczna w praktyce internistycznej: od patogenezy do terapii. Medycyna Metaboliczna, 2004, 4, 1-14.
14. Tesfaye S., Malik R., Harris N. i wsp.: Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia, 1996, 39, 329-335.
15. Tomczykiewicz K., Kotowicz J.: Ilościowe badania czucia w polineuropatiach. Medycyna po Dyplomie, 2002 (wydanie specjalne), 20-24.
16. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998, 352, 854-865.
17. Vinik A.I.: Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF). Diabetes, 1999, 48, supl. 1, A54-A55.
18. Vinik A.I, Park T.S., Stransberry K.B., Pittenger G.L.: Diabetic neuropathies. Diabetologia, 2000, 43, 957-973.
19. Ziegler D.: Diagnosis and treatment of diabetic autonomic neuropathy. Curr. Diab. Rep., 2001, 1 (3), 216-227.
20. Ziegler D.: Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol., 2004, 3 (3), 173-189.